Serum PSA as a tumor marker for patients undergoing definitive radiation therapy

G. K. Zagars

Research output: Contribution to journalReview articlepeer-review

58 Scopus citations

Abstract

This article summarizes the clinical utility of PSA both as pretreatment prognostic factor and as an invaluable post-treatment marker. Some pathobiologic correlations between serum PSA kinetics and putative tumor cell kinetic mechanisms are discussed.

Original languageEnglish (US)
Pages (from-to)737-747
Number of pages11
JournalUrologic Clinics of North America
Volume20
Issue number4
StatePublished - 1993

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Serum PSA as a tumor marker for patients undergoing definitive radiation therapy'. Together they form a unique fingerprint.

Cite this